NCT05123456

Brief Summary

The main objective of this study is to compare, with a minimum follow-up of 5 years, the prevalence of femoro-tibial osteoarthritis after an isolated ACL ligamentoplasty or after an ACL ligamentoplasty combining ACL and ALL.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

November 9, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 17, 2021

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2021

Completed
Last Updated

November 17, 2021

Status Verified

November 1, 2021

Enrollment Period

1 year

First QC Date

November 9, 2021

Last Update Submit

November 9, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of the prevalence of femoro-tibial osteoarthritis

    The prevalence of femoro-tibial osteoarthritis will be assessed by the percentage of patients with cartilage damage to the femoro-tibial compartments on a single X-ray of the face compared to 30 °of flexion.

    1 day

Study Arms (2)

Patient operated with isolated ACL knee reconstruction

EXPERIMENTAL
Procedure: Radiography

Patient operated with ACL and ALL knee reconstruction

EXPERIMENTAL
Procedure: Radiography

Interventions

RadiographyPROCEDURE

Comparative X-ray of the single knee at 30 ° flexion.

Patient operated with ACL and ALL knee reconstructionPatient operated with isolated ACL knee reconstruction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who underwent an isolated Anterior Cruciate Ligament (ACL) reconstruction or a combined ACL and anterolateral ligament reconstruction (Extra Articular Plasty) between January 1, 2011 and March 31, 2012.
  • Patients affiliated or beneficiaries of a social security scheme
  • Patients who have given their express consent.

You may not qualify if:

  • Patients with pediatric ACL reconstruction technique
  • Patients with a complex associated gesture such as osteotomy or ligamentoplasty other than extra articular plastic surgery.
  • Contraindication to a radio control (pregnancy)
  • Patient's refusal to participate in the study
  • Protected patients: Adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision; Pregnant, breastfeeding or parturient woman; Hospitalized without consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital privé Jean Mermoz

Lyon, 69008, France

RECRUITING

Related Publications (1)

  • Shatrov J, Freychet B, Hopper GP, Coulin B, El Helou A, An JS, Vieira TD, Sonnery-Cottet B. Radiographic Incidence of Knee Osteoarthritis After Isolated ACL Reconstruction Versus Combined ACL and ALL Reconstruction: A Prospective Matched Study From the SANTI Study Group. Am J Sports Med. 2023 Jun;51(7):1686-1697. doi: 10.1177/03635465231168899. Epub 2023 May 8.

MeSH Terms

Conditions

Knee Injuries

Interventions

X-Rays

Condition Hierarchy (Ancestors)

Leg InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

Electromagnetic RadiationElectromagnetic PhenomenaMagnetic PhenomenaPhysical PhenomenaRadiationRadiation, Ionizing

Central Study Contacts

Jean-François Oudet

CONTACT

Marie-Hélène Barba

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 9, 2021

First Posted

November 17, 2021

Study Start

April 15, 2020

Primary Completion

April 15, 2021

Study Completion

December 15, 2021

Last Updated

November 17, 2021

Record last verified: 2021-11

Locations